News + Resources
Keep up with the latest
Featured
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
CRISPR 2.0, the Next Generation
June 21, 2024
Aspen Ideas: Health
CRISPR 2.0, the Next Generation
June 21, 2024
All Stories
News
CasX start-up Scribe Therapeutics raises $100 million for CRISPR therapies
March 31, 2021
Chemical & Engineering News
Read Now
Press Release
CasX start-up Scribe Therapeutics raises $100 million for CRISPR therapies
March 31, 2021
Chemical & Engineering News
Read Now
News
With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge
January 15, 2021
Barron's
Read Now
Press Release
With Rare Speed, Gene Editing Emerges as Biotech’s New Cutting Edge
January 15, 2021
Barron's
Read Now
News
Top Life Sciences Startups to Watch in 2021
January 6, 2021
BioSpace
Read Now
Press Release
Top Life Sciences Startups to Watch in 2021
January 6, 2021
BioSpace
Read Now
News
2020 Was the Turning Point for CRISPR
December 14, 2020
Future Human
Read Now
Press Release
2020 Was the Turning Point for CRISPR
December 14, 2020
Future Human
Read Now